Item(by='pkaye', descendants=None, kids=[25828038, 25829054], score=None, time=1610993741, title=None, item_type='comment', url=None, parent=25823210, text='One of the things that EU countries do is negotiate with the the drug manufacturers. So UK in this case of Lumacaftor, didn&#x27;t cover the drug until they got a reasonable price. This meant a 4 year delay in access to the drug vs the US.<p>&gt; It was approved for medical use in the United States in 2015, and in Canada in 2016.[3][5] In the United States it costs more than $US 22,000 a month as of 2018.[6][7] While its use was not recommended in the United Kingdom as of 2018,[4] pricing was agreed upon in 2019 and it is expected to be covered by November of that year.[8]<p><a href="https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Lumacaftor&#x2F;ivacaftor" rel="nofollow">https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Lumacaftor&#x2F;ivacaftor</a>')